SGLT2 inhibitors
Advertisement
A study assessed whether the cardiovascular and renal effects of canagliflozin are dose dependent.
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Researchers assessed how prescription rates of SGLT2i were affected when DKD risk was predicted by a KidneyIntelX test.
Research examined kidney endpoints between patients with type 2 diabetes after initiating an SGLT2i or GLP-1RA.
A review and meta-analysis assessed the influence of SGLT2i therapy on clinically relevant hyperuricemic events.
Direct comparisons of kidney and cardiovascular outcomes with GLP-1 RAs and SGLT2i in type 2 diabetes are lacking.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
In those with more nephrology visits in the proceeding 12 months, the odds of SGLT2 inhibitor prescription were lower.
Sodium-glucose transport protein 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, block SGLT2 cotransporters in the ...
During a poster session at the American Society of Nephrology Kidney Week 2022, Thomas Mavrakanas, MD, MSc, and ...
Previous studies have shown that the use of sodium glucose linked transporter inhibitors (SGLT-2i) in nontransplant ...
Coronary Heart Disease Risk Factors and Serum Expression Analysis
...
Editor's Note: This content was written by Amit Goyal, MD, a cardiology fellow at the Cleveland Clinic, and co-founder ...
Donna Shu-Han Lin, MD, and colleagues at National Taiwan University Hospital, Taipei, Taiwan, conducted a meta-analysis ...
Of the approximately one in 11 adults worldwide with diabetes, 90% have type 2 diabetes mellitus. Globally, the ...
The manufacturers of Jardiance (empagliflozin) accounted that the FDA has granted FastTrack status to the drug for the ...
Dapagliflozin appears safe and effective across different diuretic subgroups of heart failure patients, a new analysis ...
This week's edition features some drug updates: one on SGLT-2 inhibitors in type 2 diabetic patients, and another on ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.